AngioDynamics Forecasts Fiscal Year 2025 Adjusted EPS Of $(0.38)-$(0.42), Compared To Fiscal 2024 Pro Forma Adjusted EPS Of $(0.45) Versus Consensus Of $(0.49)
Portfolio Pulse from Benzinga Newsdesk
AngioDynamics has forecasted its fiscal year 2025 adjusted EPS to be between $(0.38) and $(0.42), an improvement from the fiscal year 2024 pro forma adjusted EPS of $(0.45), which is better than the consensus estimate of $(0.49).
July 16, 2024 | 10:48 am
News sentiment analysis
Sort by:
Ascending
POSITIVE IMPACT
AngioDynamics has provided a forecast for fiscal year 2025 adjusted EPS to be between $(0.38) and $(0.42), which is an improvement from the fiscal year 2024 pro forma adjusted EPS of $(0.45) and better than the consensus estimate of $(0.49).
The forecasted improvement in adjusted EPS for fiscal year 2025 compared to fiscal year 2024 and the better-than-expected performance relative to consensus estimates are likely to positively impact AngioDynamics' stock price in the short term.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100